HUMMINGBIRD BIOSCIENCE
Hummingbird Bioscience uses systems biology to develop insights into disease biology and applies computationally guided platforms to discover and engineer breakthrough biotherapeutics. The company is pursuing a broad pipeline of first drug candidates across multiple challenging targets with strong biological validation and disease association, including lead assets: HMBD-001, an anti-HER3 antibody, and HMBD-002, an anti-VISTA antibody, for the treatment of cancer. Hummingbird has established strategic collaborations with Cancer Research UK and Amgen, and has been awarded a product development grant from the Cancer Prevention and Research Institute of Texas.
HUMMINGBIRD BIOSCIENCE
Industry:
Biotechnology Health Care Therapeutics
Founded:
2014-01-01
Address:
Woodlands, North Region, Singapore
Country:
Singapore
Website Url:
http://www.hummingbirdbioscience.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
150 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Domain Not Resolving
Current Advisors List
![]()

Current Employees Featured
![]()
Founder
Investors List
![]()
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series C - Hummingbird Bioscience
![]()
Novo Holdings
Novo Holdings investment in Series C - Hummingbird Bioscience
Octagon Capital Advisors
Octagon Capital Advisors investment in Series C - Hummingbird Bioscience
Pureos Bioventures
Pureos Bioventures investment in Series C - Hummingbird Bioscience
EDBI
EDBI investment in Series C - Hummingbird Bioscience
![]()
Amgen Ventures
Amgen Ventures investment in Series C - Hummingbird Bioscience
![]()
Mirae Asset Venture Investment
Mirae Asset Venture Investment investment in Series C - Hummingbird Bioscience
![]()
Droia Ventures
Droia Ventures investment in Series C - Hummingbird Bioscience
Polaris Partners
Polaris Partners investment in Series C - Hummingbird Bioscience
Heritas Capital
Heritas Capital investment in Series C - Hummingbird Bioscience
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-01 | Hummingbird Bioscience Strengthens Leadership Team with Appointment of Josh House as Chief Financial Officer |
Official Site Inspections
http://www.hummingbirdbioscience.com Semrush global rank: 4.05 M Semrush visits lastest month: 3.02 K
- Host name: 51.225.174.34.bc.googleusercontent.com
- IP address: 34.174.225.51
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
